Domestic steel producer Zekelman Industries filed a lawsuit on Oct. 21 in a Washington, D.C., federal court alleging that the Mexican government breached its 2019 agreement with the U.S. to slow imports of Mexican steel products. The company argued that Mexico's breach of the deal "has devastated the U.S. steel industry," forcing the company to close two plants due to the oversupply of cheap steel (Zekelman Industries v. United States, D.D.C. # 24-02992).
Trade Law Daily is providing readers with the top stories from last week, in case you missed them. All articles can be found by searching on the title or by clicking on the hyperlinked reference number.
The Office of the U.S. Trade Representative is seeking applications for people who can serve on dispute panels reviewing final determinations in antidumping or countervailing duty proceedings when the exporter is from Mexico or Canada. The service period will begin April 1 and run through March 31, 2026. Applications are due by Nov. 29.
The U.S. on Oct. 15 urged the Court of International Trade to dismiss a suit from importer Retractable Technologies challenging the recent 100% increase of Section 301 tariffs on needles and syringes from China. The government said the trade court lacks jurisdiction to "second-guess the President's findings" and discretion in telling the U.S. trade representative to modify the Section 301 action and that the company failed to state a claim on which relief could be provided (Retractable Technologies v. United States, CIT # 24-00185).
The Court of International Trade on Oct. 9 denied importer Retractable Technologies' motion to quash a prehearing deposition subpoena from the U.S. in the company's suit against the Office of the U.S. Trade Representative's 100% Section 301 rate hike on needles and syringes (Retractable Technologies v. U.S., CIT # 24-00185).
Importer Retractable Technologies on Oct. 8 asked the Court of International Trade to quash the government's motion seeking corporate testimony from the company in Retractable's suit on the Office of the U.S. Trade Representative's 100% Section 301 tariff hike on needles and syringes. Retractable said an upcoming evidentiary hearing before the trade court will give the government the information it seeks and that reasonable time wasn't allowed for the company to respond to the subpoena (Retractable Technologies v. United States, CIT # 24-00185).
The Court of International Trade on Oct. 1 ordered that an evidentiary hearing be held on Oct. 16 in a suit from importer Retractable Technologies on the Office of the U.S. Trade Representative's 100% Section 301 tariff hike on needles and syringes. The importer filed the suit to seek a temporary restraining order and a preliminary injunction on the duties, claiming the tariffs could send it out of business (see 2409270025) (Retractable Technologies v. United States, CIT # 24-00185).
The following lawsuits were recently filed at the Court of International Trade:
Texas-based syringe importer Retractable Technologies took to the Court of International Trade to contest the 100% increase of Section 301 tariffs recently imposed on needles and syringes from China. The complaint is seeking a temporary restraining order and a preliminary injunction against the duties, claiming that the tariffs could send the company out of business (Retractable Technologies v. United States, CIT # 24-00185).
Luggage importer Samsonite filed a complaint at the Court of International Trade on Aug. 29 to contest CBP's alleged failure to apply Section 301 exclusions granted by the Office of the U.S. Trade Representative to its baggage entries (Samsonite v. United States, CIT # 24-00031).